Digital health technologies continue to proliferate in the US, but unique reimbursement and market access challenges remain. The traditional medical device buy-and-bill purchasing model buoyed by payer reimbursement via standardized codes, fee schedules, and claims...

Rightsizing Your Digital Health Technology’s Evidence Generation Strategy to Meet the Needs of Key US Stakeholders
read more